Because neoplasms are able to release NKG2D ligands MICA/B and ULBP1/2/3 by proteolytic cleavage, and thus evade NKG2D-mediated NK cell cytotoxicity [283,512,513]. This evidence concerns the gene KLRK1 and neoplasm.